193 related articles for article (PubMed ID: 21499767)
1. Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences.
Cam H; Houghton PJ
Target Oncol; 2011 Jun; 6(2):95-102. PubMed ID: 21499767
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α.
Cam H; Easton JB; High A; Houghton PJ
Mol Cell; 2010 Nov; 40(4):509-20. PubMed ID: 21095582
[TBL] [Abstract][Full Text] [Related]
3. ATM engages the TSC2/mTORC1 signaling node to regulate autophagy.
Alexander A; Kim J; Walker CL
Autophagy; 2010 Jul; 6(5):672-3. PubMed ID: 20581436
[TBL] [Abstract][Full Text] [Related]
4. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS.
Alexander A; Cai SL; Kim J; Nanez A; Sahin M; MacLean KH; Inoki K; Guan KL; Shen J; Person MD; Kusewitt D; Mills GB; Kastan MB; Walker CL
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4153-8. PubMed ID: 20160076
[TBL] [Abstract][Full Text] [Related]
5. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
[TBL] [Abstract][Full Text] [Related]
6. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
7. Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kinetics.
Liu Q; Kirubakaran S; Hur W; Niepel M; Westover K; Thoreen CC; Wang J; Ni J; Patricelli MP; Vogel K; Riddle S; Waller DL; Traynor R; Sanda T; Zhao Z; Kang SA; Zhao J; Look AT; Sorger PK; Sabatini DM; Gray NS
J Biol Chem; 2012 Mar; 287(13):9742-9752. PubMed ID: 22223645
[TBL] [Abstract][Full Text] [Related]
8. The mTOR pathway negatively controls ATM by up-regulating miRNAs.
Shen C; Houghton PJ
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11869-74. PubMed ID: 23818585
[TBL] [Abstract][Full Text] [Related]
9. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia.
Wolff NC; Vega-Rubin-de-Celis S; Xie XJ; Castrillon DH; Kabbani W; Brugarolas J
Mol Cell Biol; 2011 May; 31(9):1870-84. PubMed ID: 21383064
[TBL] [Abstract][Full Text] [Related]
10. The E3 ubiquitin ligase protein associated with Myc (Pam) regulates mammalian/mechanistic target of rapamycin complex 1 (mTORC1) signaling in vivo through N- and C-terminal domains.
Han S; Kim S; Bahl S; Li L; Burande CF; Smith N; James M; Beauchamp RL; Bhide P; DiAntonio A; Ramesh V
J Biol Chem; 2012 Aug; 287(36):30063-72. PubMed ID: 22798074
[TBL] [Abstract][Full Text] [Related]
11. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity.
Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP
Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421
[TBL] [Abstract][Full Text] [Related]
12. mTOR activity under hypoxia.
Vadysirisack DD; Ellisen LW
Methods Mol Biol; 2012; 821():45-58. PubMed ID: 22125059
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress.
Young RM; Ackerman D; Quinn ZL; Mancuso A; Gruber M; Liu L; Giannoukos DN; Bobrovnikova-Marjon E; Diehl JA; Keith B; Simon MC
Genes Dev; 2013 May; 27(10):1115-31. PubMed ID: 23699409
[TBL] [Abstract][Full Text] [Related]
14. Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) is a negative regulator of the mammalian target of rapamycin complex 1 (mTORC1).
Li L; Guan KL
J Biol Chem; 2013 Jan; 288(1):703-8. PubMed ID: 23184942
[TBL] [Abstract][Full Text] [Related]
15. Tumor Suppressor Folliculin Regulates mTORC1 through Primary Cilia.
Zhong M; Zhao X; Li J; Yuan W; Yan G; Tong M; Guo S; Zhu Y; Jiang Y; Liu Y; Jiang Y
J Biol Chem; 2016 May; 291(22):11689-97. PubMed ID: 27072130
[TBL] [Abstract][Full Text] [Related]
16. ULK1 inhibits the kinase activity of mTORC1 and cell proliferation.
Jung CH; Seo M; Otto NM; Kim DH
Autophagy; 2011 Oct; 7(10):1212-21. PubMed ID: 21795849
[TBL] [Abstract][Full Text] [Related]
17. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.
Matthew EM; Hart LS; Astrinidis A; Navaraj A; Dolloff NG; Dicker DT; Henske EP; El-Deiry WS
Cell Cycle; 2009 Dec; 8(24):4168-75. PubMed ID: 20054236
[TBL] [Abstract][Full Text] [Related]
18. Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis.
Wen ZH; Su YC; Lai PL; Zhang Y; Xu YF; Zhao A; Yao GY; Jia CH; Lin J; Xu S; Wang L; Wang XK; Liu AL; Jiang Y; Dai YF; Bai XC
Oncogene; 2013 Jan; 32(2):160-70. PubMed ID: 22349822
[TBL] [Abstract][Full Text] [Related]
19. mTOR-dependent cell survival mechanisms.
Hung CM; Garcia-Haro L; Sparks CA; Guertin DA
Cold Spring Harb Perspect Biol; 2012 Dec; 4(12):. PubMed ID: 23124837
[TBL] [Abstract][Full Text] [Related]
20. Tel2 regulates the stability of PI3K-related protein kinases.
Takai H; Wang RC; Takai KK; Yang H; de Lange T
Cell; 2007 Dec; 131(7):1248-59. PubMed ID: 18160036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
